Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates

Int J Antimicrob Agents. 2012 Aug;40(2):189-90. doi: 10.1016/j.ijantimicag.2012.04.017. Epub 2012 Jun 22.

Authors

Obdulia Noguera, Natividad López-Riquelme, Juan Carlos Rodríguez, Miguel Santibañez, Ledicia Alvarez, Antonio Galiana, Montserrat Ruiz-García, Pilar López-García, Gloria Royo

PMID: 22727771
DOI: 10.1016/j.ijantimicag.2012.04.017

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Drug Resistance, Bacterial
Escherichia coli / drug effects
Escherichia coli / enzymology*
Escherichia coli / isolation & purification
Escherichia coli Infections / epidemiology
Escherichia coli Infections / microbiology
Fluoroquinolones / pharmacology
Humans
Klebsiella Infections / epidemiology
Klebsiella Infections / microbiology
Klebsiella pneumoniae / drug effects
Klebsiella pneumoniae / enzymology*
Klebsiella pneumoniae / isolation & purification
Microbial Sensitivity Tests / methods
Microbial Sensitivity Tests / standards*
Prevalence
beta-Lactamases / biosynthesis*

Substances

Fluoroquinolones
beta-Lactamases